Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Change in Cash (2024 - 2025)

Historic Change in Cash for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to $8.5 million.

  • Neuphoria Therapeutics' Change in Cash rose 32747.15% to $8.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.8 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2025, which is 21718.49% up from last year.
  • Neuphoria Therapeutics' Change in Cash amounted to $8.5 million in Q4 2025, which was up 32747.15% from -$560488.0 recorded in Q3 2025.
  • Over the past 5 years, Neuphoria Therapeutics' Change in Cash peaked at $12.7 million during Q1 2025, and registered a low of -$4.5 million during Q3 2024.